Upregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasion

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Tung, Edmund Kwok Kwan ^a,b   Wong, Betty Yin Chi ^b   Yau, Tai On ^b   Ng, Irene Oi Lin ^a,b  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; T CELL FACTOR PROTEIN; WNT PROTEIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

ADULT; AGED; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; MALE; MICE; MIDDLE AGED; NEOPLASM INVASIVENESS; WNT SIGNALING PATHWAY; YOUNG ADULT;

MUS MUSCULUS;

EID: 84860524549     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036565     Document Type: Article

References (41)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127 (12): 2893-2917.
2. Zender L, Kubicka S, (2008) Molecular pathogenesis and targeted therapy of hepatocellular carcinoma. Onkologie 31: 550-555.
3. Wong CM, Ng IO, (2008) Molecular pathogenesis of hepatocellular carcinoma. Liver Int 28: 160-174.
4. Takigawa Y, Brown AM, (2008) Wnt signaling in liver cancer. Curr Drug Targets 9: 1013-1024.
5. Llovet JM, Bruix J, (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48: 1312-1327.
6. Kim YD, Park CH, Kim HS, Choi SK, Rew JS, et al. (2008) Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma. J Gastroenterol Hepatol 23: 110-118.
7. Tommasi S, Pinto R, Pilato B, Paradiso A, (2007) Molecular pathways and related target therapies in liver carcinoma. Curr Pharm Des 13: 3279-3287.
8. Teufel A, Staib F, Kanzler S, Weinmann A, Schulze-Bergkamen H, et al. (2007) Genetics of hepatocellular carcinoma. World J Gastroenterol 13: 2271-2282.
9. Clevers H, (2006) Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
10. MacDonald BT, Tamai K, He X, (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26.
11. Wong CM, Fan ST, Ng IO, (2001) beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer 92: 136-145.
12. Li Y, Lu W, He X, Schwartz AL, Bu G, (2004) LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering beta-catenin subcellular distribution. Oncogene 23: 9129-9135.
13. Liu CC, Prior J, Piwnica-Worms D, Bu G, (2010) LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy. Proc Natl Acad Sci U S A 107: 5136-5141.
14. Zhang J, Li Y, Liu Q, Lu W, Bu G, (2010) Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis. Oncogene 29: 539-549.
15. Brennan K, Gonzalez-Sancho JM, Castelo-Soccio LA, Howe LR, Brown AM, (2004) Truncated mutants of the putative Wnt receptor LRP6/Arrow can stabilize beta-catenin independently of Frizzled proteins. Oncogene 23: 4873-4884.
16. Hu L, Wen JM, Sham JS, Wang W, Xie D, et al. (2004) Establishment of cell lines from a primary hepatocellular carcinoma and its metastatis. Cancer Genet Cytogenet 148: 80-84.
17. Chan DW, Chan CY, Yam JW, Ching YP, Ng IO, (2006) Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer. Gastroenterology 131: 1218-1227.
18. Moon RT, Kohn AD, De Ferrari GV, Kaykas A, (2004) WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691-701.
19. Park JY, Park WS, Nam SW, Kim SY, Lee SH, et al. (2005) Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis. Liver Int 25: 70-76.
20. Ishizaki Y, Ikeda S, Fujimori M, Shimizu Y, Kurihara T, et al. (2004) Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas. Int J Oncol 24: 1077-1083.
21. Devereux TR, Stern MC, Flake GP, Yu MC, Zhang ZQ, et al. (2001) CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1. Mol Carcinog 31: 68-73.
22. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, et al. (2000) AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24: 245-250.
23. Huang H, Fujii H, Sankila A, Mahler-Araujo BM, Matsuda M, et al. (1999) Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol 155: 1795-1801.
24. Hsu HC, Jeng YM, Mao TL, Chu JS, Lai PL, et al. (2000) Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am J Pathol 157: 763-770.
25. Mi K, Johnson GV, (2005) Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway. J Cell Biochem 95: 328-338.
26. Beagle B, Johnson GV, (2010) Differential modulation of TCF/LEF-1 activity by the soluble LRP6-ICD. PLoS ONE 5: e11821.
27. Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC, (2000) An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407: 535-538.
28. Tamai K, Semenov M, Kato Y, Spokony R, Liu C, et al. (2000) LDL-receptor-related proteins in Wnt signal transduction. Nature 407: 530-535.
29. Wehrli M, Dougan ST, Caldwell K, O'Keefe L, Schwartz S, et al. (2000) arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 407: 527-530.
30. Merle P, Kim M, Herrmann M, Gupte A, Lefrancois L, et al. (2005) Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma. J Hepatol 43: 854-862.
31. Merle P, de la Monte S, Kim M, Herrmann M, Tanaka S, et al. (2004) Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. Gastroenterology 127: 1110-1122.
32. Kim M, Lee HC, Tsedensodnom O, Hartley R, Lim YS, et al. (2008) Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells. J Hepatol 48: 780-791.
33. Bengochea A, de Souza MM, Lefrancois L, Le Roux E, Galy O, et al. (2008) Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer 99: 143-150.
34. Zhang Z, Schittenhelm J, Guo K, Buhring HJ, Trautmann K, et al. (2006) Upregulation of frizzled 9 in astrocytomas. Neuropathol Appl Neurobiol 32: 615-624.
35. Kirikoshi H, Sekihara H, Katoh M, (2001) Expression profiles of 10 members of Frizzled gene family in human gastric cancer. Int J Oncol 19: 767-771.
36. Janssens N, Andries L, Janicot M, Perera T, Bakker A, (2004) Alteration of frizzled expression in renal cell carcinoma. Tumour Biol 25: 161-171.
37. Li Y, Bu G, (2005) LRP5/6 in Wnt signaling and tumorigenesis. Future Oncol 1: 673-681.
38. Hoang BH, Kubo T, Healey JH, Sowers R, Mazza B, et al. (2004) Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma. Int J Cancer 109: 106-111.
39. Guo Y, Rubin EM, Xie J, Zi X, Hoang BH, (2008) Dominant negative LRP5 decreases tumorigenicity and metastasis of osteosarcoma in an animal model. Clin Orthop Relat Res 466: 2039-2045.
40. Bjorklund P, Svedlund J, Olsson AK, Akerstrom G, Westin G, (2009) The internally truncated LRP5 receptor presents a therapeutic target in breast cancer. PLoS ONE 4: e4243.
41. Bjorklund P, Akerstrom G, Westin G, (2007) An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/beta-catenin signaling. PLoS Med 4: e328.